Efficacy of Guselkumab, a Monoclonal Antibody That Specifically Binds to the p19 Subunit of IL-23, on Axial-Related Endpoints in Patients with Active PsA with Imaging-Confirmed Sacroiliitis: Week-52 Results from Two Phase 3, Randomized, Double-blind, Placebo-controlled Studies

Mease, P, Helliwell, P orcid.org/0000-0002-4155-9105, Gladman, D et al. (15 more authors) (2020) Efficacy of Guselkumab, a Monoclonal Antibody That Specifically Binds to the p19 Subunit of IL-23, on Axial-Related Endpoints in Patients with Active PsA with Imaging-Confirmed Sacroiliitis: Week-52 Results from Two Phase 3, Randomized, Double-blind, Placebo-controlled Studies. In: 37º Congresso Brasileiro de Reumatologia, 19-22 Nov 2020, Virtual.

Metadata

Authors/Creators:
  • Mease, P
  • Helliwell, P ORCID logo https://orcid.org/0000-0002-4155-9105
  • Gladman, D
  • Poddubnyy, D
  • Baraliakos, X
  • Chakravarty, SD
  • Kollmeier, AP
  • Hsia, EC
  • Xu, L
  • Sheng, S
  • Agarwal, P
  • Zhou, B
  • Shawi, M
  • Karyekar, CS
  • Gomes, RT
  • Sweet, K
  • Deodhar, A
  • van der Heijde, D
Dates:
  • Published: October 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Oct 2021 09:16
Last Modified: 14 Oct 2021 09:16
Status: Published
Identification Number: https://doi.org/10.47660/CBR.2020.17503
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)